Acute Radiation Syndrome Disease Briefing now freely available in pdf format
Thomson Reuters is making available resources from Thomson Reuters IntegritySM to drug development professionals in order to promote the free flow of vital information on acute radiation syndrome (ARS), the existing treatments, and the drugs in active development to combat ARS.
The Acute Radiation Syndrome Disease Briefing has been added to support those involved in drug research and development projects in this area. As of May 2011, this report has been updated to include expanded Targets and Treatments sections, and three new sections (Diagnosis, Classification of Severity, and Radiomitigants), in addition to an increased number of tables and figures. View the full report.